The SARS‐CoV‐2 Omicron (B.1.1.529) variant and effectiveness of existing vaccines: What we know so far

Author:

Sohan Md.1ORCID,Hossain Md. Jamal2ORCID,Islam Md. Rabiul1ORCID

Affiliation:

1. Department of Pharmacy University of Asia Pacific Dhaka Bangladesh

2. Department of Pharmacy State University of Bangladesh Dhaka Bangladesh

Publisher

Wiley

Subject

Infectious Diseases,Virology

Reference23 articles.

1. SARS-CoV-2 Omicron variant shows less efficient replication and fusion activity when compared with Delta variant in TMPRSS2-expressed cells

2. mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant

3. Omicron: A Speculation on Its Potential Superpowers

4. SARS‐CoV‐2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection;Cele S;medRxiv,2021

5. Omicron variant and booster COVID‐19 vaccines;Burki TK;Lancet Respir Med,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3